Skip to main content

and
  1. Article

    Open Access

    Author Correction: Liquid biopsy epigenomic profiling for cancer subty**

    Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato in Nature Medicine (2024)

  2. Article

    Open Access

    Liquid biopsy epigenomic profiling for cancer subty**

    Although circulating tumor DNA (ctDNA) assays are increasingly used to inform clinical decisions in cancer care, they have limited ability to identify the transcriptional programs that govern cancer phenotypes...

    Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato in Nature Medicine (2023)

  3. Article

    Open Access

    Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer

    The downstream targets of hypoxia inducible factor-1 alpha (HIF-1α) play an important role in tumor progression and angiogenesis. Therefore, inhibition of HIF-mediated transcription has potential in the treatm...

    Kelie M Reece, Emily D Richardson, Kristina M Cook, Tessa J Campbell in Molecular Cancer (2014)